Katarzyna Zych-Krekora

Dr. Katarzyna Zych-Krekora

Perinatology, Obstetric and Gynecology Department, Research institute Polish Mother's Memorial Hospital ,Lodz, Poland
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2018 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
MSMaciej Słodki
Maciej Słodki
RARoland Axt‐Fliedner
Roland Axt‐Fliedner
KZKatarzyna Zych-Krekora
Katarzyna Zych-Krekora
AWAline Wolter
Aline Wolter
AKAndreea Kawecki
Andreea Kawecki
TGThe International Prenatal Cardiology Collaboration Group
The International Prenatal Cardiology Collaboration Group

5 September 2018 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
MSMaciej Słodki
Maciej Słodki
Giuseppe RizzoGiuseppe Rizzo
Giuseppe Rizzo
AAAnna Augustyniak
Anna Augustyniak
NSNeil S. Seligman
Neil S. Seligman
KZKatarzyna Zych-Krekora
Katarzyna Zych-Krekora
TGThe International Prenatal Cardiology Collaboration Group
The International Prenatal Cardiology Collaboration Group
Introduction: Prenatal diagnosis of congenital heart disease (CHD) leads to improved outcome but not mortality rate. This may not be the case for coarctation of the aorta (CoA). The objective of this study is to estimate the effect of a prenatal diagnosis of CoA by comparing neonates with CoA by the time of diagnosis. Materials and methods: The study included 38 neonates with CoA diagnosed prenatally and 102 neonates diagnosed postnatally. The postnatal group was divided into two subgroups: (1) severe CoA: symptoms of CoA within the first 7 days (n = 43) and (2) mild CoA: symptoms within the 8–28th day (n = 34). The neonates diagnosed more than 28 days after delivery were excluded from the study (n = 25). Severe CoA was defined as CHD diagnosed postnatally with clinical symptoms that presented in the first week after birth. Mild CoA was defined as CHD that presented clinical symptoms later than 7 days of life. Results: Prostaglandins were initiated at lower doses (p < .001) in the prenatal group. Severe postnatal CoA was associated with more frequent Neonatal Intensive Care Unit (NICU) visits than mild postnatal CoA (p = .005). The length of hospitalization of neonates with severe postnatal CoA was 10 days longer than compared to the prenatal group, but the difference was not statistically significant. The highest mortality rate was in the severe postnatal CoA group (18.6%) which was significantly higher than the mortality rate in the prenatal group (p = .005). Conclusion: 1. Prenatal identification of fetuses at increased risk of developing CoA may reduce mortality and improve outcome only in neonates with severe CoA (symptoms of CoA within the first 7 days after birth); 2. Prenatal diagnosis of severe CoA was associated with lower prostaglandin doses and lower mortality rate.

12 July 2017 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
RARoland Axt-Fliedner
Roland Axt-Fliedner
AKAndrii Kurkevych
Andrii Kurkevych
MSMaciej Słodki
Maciej Słodki
MRMaria Respondek-Liberska
Maria Respondek-Liberska
KZKatarzyna Zych-Krekora
Katarzyna Zych-Krekora
OGon behalf of the International Prenatal Cardiology Collaboration Group
on behalf of the International Prenatal Cardiology Collaboration Group

Verified
Journal Article
Open access
PDF file
KZKatarzyna Zych-Krekora
Katarzyna Zych-Krekora
OSOskar Sylwestrzak
Oskar Sylwestrzak
MKMichał Krekora
Michał Krekora
Background/Objectives: Iron is a fundamental micronutrient. Its deficiency could have a potentially harmful influence on maternal and fetal well-being. Methods: This review synthesizes current evidence on the epidemiology, consequences, and clinical meaning of iron deficiency (ID) and iron deficiency anemia (IDA) in pregnant women. Results: Untreated ID in pregnancy is associated with a wide spectrum of adverse outcomes: maternal clinical symptoms, cardiovascular disturbances, preterm birth, low birth weight, and impaired fetal neurodevelopment. Furthermore, ID has been related to impaired implantation, miscarriage, congenital heart defects, and neurological complications in fetuses. Women with gastrointestinal disorders and low socioeconomic status constitute a high-risk group of developing IDA. ID remains underdiagnosed and suboptimally managed in some clinical practices. Conclusions: This review highlights the critical importance of early detection, individualized supplementation, and public health interventions aimed at reducing iron deficiency during pregnancy.

4 August 2021 in Archives of Medical Science
Verified
Journal Article
Open access
YGYinon Gilboa
Yinon Gilboa
MKMichał Krekora
Michał Krekora
SPSharon Perlman
Sharon Perlman
RBRon Bardin
Ron Bardin
EKEran Kassif
Eran Kassif
ZKZvi Kivilevitch
Zvi Kivilevitch
Introduction: The aim of our study was to assess fetal pancreas size of the in a population of well controlled mothers with gestational diabetes. Material and methods: A cross sectional, prospective observational study. Pregnant women at 19-38 weeks of gestation who received glycemic control...

9 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KZKatarzyna Zych-Krekora
Katarzyna Zych-Krekora
MKMichał Krekora
Michał Krekora
MGMariusz Grzesiak
Mariusz Grzesiak
OSOskar Sylwestrzak
Oskar Sylwestrzak
Background: Aortic coarctation (CoA) is the fourth most common congenital heart defect (8–10%) which occurs at a frequency of about 20–60/100,000 births. Only 22.3% of all cases appears to be diagnosed during the second trimester of pregnancy. Since the detection of prenatal aortic coarctations is very low, every effort should be made to change this situation. According to the authors of this study, the CSAi (carotid to subclavian artery index) could serve as a reliable indicator. Material and Methods: Ninety-six fetuses from healthy, single, pregnancies, with good ultrasound visualization between 18 and 27.5 weeks of gestation, and twenty-three fetuses suspected of aortic coarctation (postnatally confirmed) were included in this study. Our first aim was to compare the current most common method of prenatal CoA diagnosis based on the measurement of the aortic z-score in the aortic isthmus using the method suggested by us-CSAi. Results: Logistic regression coefficients for z-score and CSAi were analyzed as predictors of coarctation occurrence. It appears that 39.4% of coarctation occurrence can be predicted on the basis of the z-score, and 93.5% on the basis of the CSAi. The cut-off value for CSAi in the study group was 0.81 (sensitivity: 95.7%, specificity 99%). Based on the ROC curve analysis, the cut-off value for the carotid to subclavian distance (mm) was determined; the risk of coarctation increased above this value. Based on the Gini index (0.867), this value was set at 2.55 (sensitivity 82.6%, specificity 93.7%). Conclusions: CSAi measurement is currently the most sensitive method for aortic coarctation detection. For the purpose of our study, this method was applied in diagnostics in the second trimester of pregnancy. This method is easy, reproducible and should be widely introduced into everyday echocardiographic diagnostics of coarctation to minimize the risk of error.